117 related articles for article (PubMed ID: 8343190)
1. Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease.
Castor CW; Andrews PC; Swartz RD; Ellis SG; Hossler PA; Clark MR; Matteson EL; Sachter EF
Arthritis Rheum; 1993 Aug; 36(8):1142-53. PubMed ID: 8343190
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell culture.
Castor CW; Smith EM; Hossler PA; Bignall MC; Aaron BP
Arthritis Rheum; 1992 Jul; 35(7):783-93. PubMed ID: 1622417
[TBL] [Abstract][Full Text] [Related]
3. Regulation of glucose transporters by connective tissue activating peptide-III isoforms.
Tai PK; Liao JF; Hossler PA; Castor CW; Carter-Su C
J Biol Chem; 1992 Sep; 267(27):19579-86. PubMed ID: 1527075
[TBL] [Abstract][Full Text] [Related]
4. Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III.
Castor CW; Walz DA; Johnson PH; Hossler PA; Smith EM; Bignall MC; Aaron BP; Underhill P; Lazar JM; Hudson DH
J Lab Clin Med; 1990 Oct; 116(4):516-26. PubMed ID: 2212861
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue activation XXXVIII: heparin/heparanase activity of human platelets resides in a high molecular weight protein, not in connective tissue activating peptide III.
Castor CW; Kotlyar A; Edwards BE
J Rheumatol; 2002 Nov; 29(11):2337-44. PubMed ID: 12415589
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue activation. XXXIII. Biologically active cleavage products of CTAP-III from human platelets.
Castor CW; Walz DA; Ragsdale CG; Hossler PA; Smith EM; Bignall MC; Aaron BP; Mountjoy K
Biochem Biophys Res Commun; 1989 Sep; 163(2):1071-8. PubMed ID: 2783111
[TBL] [Abstract][Full Text] [Related]
7. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor.
Castor CW; Miller JW; Walz DA
Proc Natl Acad Sci U S A; 1983 Feb; 80(3):765-9. PubMed ID: 6572368
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
Härter L; Petersen F; Flad HD; Brandt E
J Immunol; 1994 Dec; 153(12):5698-708. PubMed ID: 7989767
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue activation. XVII. Radioimmunoassay of a human platelet derived connective tissue activating peptide (CTAP-III) and specificities of anti-CTAP-III sera.
Weiss JJ; Meyers S; Castor CW; Donakowski C; Anderson B
Clin Chim Acta; 1980 Dec; 108(3):425-33. PubMed ID: 7471473
[TBL] [Abstract][Full Text] [Related]
10. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III.
Brandt E; Van Damme J; Flad HD
Cytokine; 1991 Jul; 3(4):311-21. PubMed ID: 1873479
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue activation. XXIII. Increased plasma levels of a platelet growth factor (CTAP-III) in patients with rheumatic diseases.
MacCarter DK; Hossler PA; Castor CW
Clin Chim Acta; 1981 Sep; 115(2):125-34. PubMed ID: 6974622
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
Reddigari SR; Kuna P; Miragliotta GF; Kornfeld D; Baeza ML; Castor CW; Kaplan AP
J Allergy Clin Immunol; 1992 Mar; 89(3):666-72. PubMed ID: 1372016
[TBL] [Abstract][Full Text] [Related]
13. Connective tissue activation. XXXI. Identification of two molecular forms of a human mesenchymal cell-derived growth factor, connective tissue activating peptide-V.
Cabral AR; Castor CW
Arthritis Rheum; 1987 Dec; 30(12):1382-92. PubMed ID: 3325065
[TBL] [Abstract][Full Text] [Related]
14. Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator.
Castor CW; Ritchie JC; Williams CH; Scott ME; Whitney SL; Myers SL; Sloan TB; Anderson BE
Arthritis Rheum; 1979 Mar; 22(3):260-72. PubMed ID: 420716
[TBL] [Abstract][Full Text] [Related]
15. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
Car BD; Baggiolini M; Walz A
Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue activation XIX. Plasma levels of the CTAP-III platelet antigen in rheumatoid arthritis.
Myers SL; Hossler PA; Castor CW
J Rheumatol; 1980; 7(6):814-9. PubMed ID: 7205823
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue activation. XXII. A platelet growth factor (connective tissue-activating peptide-III) in human growth hormone-deficient patients.
Castor CW; Cobel-Geard SR; Hossler PA; Kelch RP
J Clin Endocrinol Metab; 1981 Jan; 52(1):128-32. PubMed ID: 6778888
[TBL] [Abstract][Full Text] [Related]
18. Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions.
Ehlert JE; Gerdes J; Flad HD; Brandt E
J Immunol; 1998 Nov; 161(9):4975-82. PubMed ID: 9794434
[TBL] [Abstract][Full Text] [Related]
19. Megakaryocyte maturation is associated with expression of the CXC chemokine connective tissue-activating peptide CTAP III.
Deutsch V; Bitan M; Friedmann Y; Eldor A; Vlodavsky I
Br J Haematol; 2000 Dec; 111(4):1180-9. PubMed ID: 11167759
[TBL] [Abstract][Full Text] [Related]
20. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
